期刊文献+

酵母过氧化物体生物合成缺陷突变株的诱变、筛选和鉴定 被引量:2

Mutagenesis,screening and characterization of mutants known as peroxisome biogenesis disorders in yeast
下载PDF
导出
摘要 过氧化物体对生物的生长和发育非常重要,人类很多疾病就是由于过氧化物体生物合成缺陷引起。以解脂耶氏酵母E122为出发菌,采用硫酸二乙酯诱变,获得了两株过氧化物体生物合成缺陷突变株,其中一株为温度敏感的突变株。在正常生长条件下,突变株的免疫荧光分析显示弥散的染色模式,且在电镜下观察不到过氧化物体的形态结构。将克隆于表达载体pINA445上的目前所发现的与过氧化物体生物合成有关的基因转化这两株突变株,发现它们均不能恢复其在含油酸的培养基上的生长,表明这两个突变株是由与过氧化物体生物合成相关的新基因的突变引起。这两个突变株的获得为参与过氧化物体生物合成的新基因的发现奠定了基础。 Peroxisomes are essential for organisms' development and physiology. This fact is underscored by the lethality of a group of genetic disorders collectively known as the peroxisome biogenesis disorders ( PBDs), such as Zellweger syndrome, in which peroxisomes fail to assemble properly. Defining the molecular bases of the PBDs has been the impetus behind the identification of the genes controlling peroxisome assembly, the PEX genes, from various modern organisms. Here as a original strain, Yarrowia lipolytica E122 was mutated by diethyl sulfate (DES) treatment and two mutants including temperature sensitive one were obtained. Compared to the initial strain, the two mutants showed more diffuse pattern of fluorescence characteristic of a cytosolic localization in immunofluorescence analysis, and showed no morphologically recognizable peroxisomes in electron micrographs. The two mutants arose from new gene mutation characterized by transformation and will be very useful in identification of new gene controlling peroxisome assembly from yeast.
出处 《微生物学报》 CAS CSCD 北大核心 2006年第3期470-473,共4页 Acta Microbiologica Sinica
基金 国家自然科学基金(39860037) 江西省自然科学基金(0630012)~~
关键词 解脂耶氏酵母 过氧化物体 生物合成缺陷 诱变 筛选 Yarrowia lipolytica Peroxisome biogenesis disorder Mutagenesis Screening
  • 相关文献

参考文献18

  • 1Eckert JH,Erdmann R.Peroxisome biogenesis.Rev Physio Biochem Pharmaco,2003,147:75-121.
  • 2Titorenko Ⅵ,Rachubinski RA.The life cycle of the peroxisome.Nat Rev Mol Cell Biol,2001,2:357-368.
  • 3Smith MD,Schnell DJ.Peroxisomal protein import:The paradigm shifts.Cell,2001,105:293-296.
  • 4Rachubinski RA,Subramani S.How proteins penetrate peroxisomes.Cell,1995,83:525-528.
  • 5Freedman BD,Lee EJ,Park YK,et al.A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome.J Biol Chem,2005,280:17118-17125.
  • 6Barth PG,Majoie CB,Gootjes J,et al.Neuroimaging of peroxisome biogenesis disorders (Zellweger spectrum) with prolonged survival.Neurology,2004,62:439-444.
  • 7Kersten S,Desvergne B,Wahli W.Roles of PPARs in health and disease.Nature,2000,405:421-424.
  • 8Maxwell MA,Allen T,Solly PB,et al.Novel PEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis diorder patients.Hum Mutat,2002,20:342-351.
  • 9Shimozawa N,Tsukamoto T,Suzuki Y,et al.A human gene responsible for Zellweger syndrome that affects peroxisome assembly.Science,1992,255:1132-1134.
  • 10Wanders R,Waterham H.Peroxisomal disorders I:biochemistry and genetics of peroxisome biogenesis disorders.Clin Genet,2005,67:107-133.

同被引文献28

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部